Evidence check: Menopause Check in the context of skin aging

Menopause significantly impacts skin aging due to estrogen decline, leading to collagen loss, dryness, reduced elasticity, and wrinkle formation. A 'Menopause Check' offered by direct-to-consumer tests (DNA or blood) claims to predict or manage these skin changes. Evidence is mixed: hormone panels (FSH, estradiol) can confirm menopausal stage, but their predictive power for skin aging is limited. Genetic variants in collagen or estrogen receptor genes show weak, often unreplicated associations. Most commercial tests rely on mechanistic plausibility rather than robust clinical trials. Lifestyle interventions (sun protection, antioxidants, moisturizers) and medically supervised hormone therapy have stronger support. Caution: these tests may lead to unnecessary supplementation or anxiety. They are not diagnostic for skin aging. Evidence: mechanistic/mixed. Consult a dermatologist or gynecologist for personalized advice.